Sinus-Rhythm
发表于 2025-3-23 10:45:35
http://reply.papertrans.cn/71/7030/702948/702948_11.png
hypnogram
发表于 2025-3-23 14:16:02
results achieved so far with conventional therapy using systemic corticosteroids and cytotoxic agents, new treatment modalities have been sought. a) Start treatment with Sandimmun at initial doses of During the last four years, a total of over 300 patients 5 mg/kg/day. b) Use Sandimmun in combinatio
维持
发表于 2025-3-23 21:00:13
http://reply.papertrans.cn/71/7030/702948/702948_13.png
OFF
发表于 2025-3-23 23:42:02
Present Experience with Sandimmun,ine, (97 patients) or placebo (12 patients). Most patients receiving Sandimmun had an initial loading dose of 5 to 10 mg/kg/day followed by a dose reduction according to ocular inflammatory activity and tolerability.
Directed
发表于 2025-3-24 04:39:22
Introduction: Endogenous Uveitis, to the iris (iritis), the ciliary body (cyclitis) or both (iridocyclitis), the manifestation is coined anterior uveitis. Localization of the inflammatory reaction to the pars plana and peripheral fundus (pars planitis) as well as vitreous (vitritis) is coined intermediate uveitis, while posterior u
牛的细微差别
发表于 2025-3-24 06:38:41
Conference proceedings 1988Latest editionndent studies all over the d) Taper Sandimmun dose as rapidly as possible to a world (over 200 patients) and in a masked manner in 4 maintenance dose below 5 mg/kg/day. e) Do not discontinue treatment with Sandimmun rap independent controlled studies (over 100 patients re idly.
精密
发表于 2025-3-24 12:24:38
http://reply.papertrans.cn/71/7030/702948/702948_17.png
谦卑
发表于 2025-3-24 15:51:40
http://reply.papertrans.cn/71/7030/702948/702948_18.png
PHON
发表于 2025-3-24 20:32:39
D. BenEzra M.D., Ph.D.,R. B. Nussenblatt M.D.,P. Timonen M.B.
Obloquy
发表于 2025-3-25 00:38:40
D. BenEzra M.D., Ph.D.,R. B. Nussenblatt M.D.,P. Timonen M.B.